Newsroom

by: visiort_billy

|

Categories: Press Announcements

|

0 Comments

22 March 2017. The International Journal of Radiation Oncology, Biology and Physics has published a study from University of North Carolina (UNC) on the use of Vision RT’s AlignRT for Deep Inspiration Breath Hold (DIBH)¹ during left breast radiation therapy. This study produced data suggesting that AlignRT helps prevent heart blood flow abnormalities, and heart […]

by: visiort_billy

|

Categories: Press Announcements

|

0 Comments

26 September 2016. Novant Health, a nationally accredited institution in the USA, has become the first cancer care provider in the world to provide Surface Guided Radiotherapy (SGRT) treatment techniques using Elekta’s Response gating interface and Vision RT’s AlignRT® patient motion monitoring system on their Elekta Versa HD™ treatment delivery system. As more and more […]

by: visiort_billy

|

Categories: Press Announcements

|

0 Comments

6 April 2016. Vision RT, the developer of world-leading motion management tools for radiotherapy, today announces that it has appointed Mike Schneider in the new role of VP Global Customer Support. Mike comes to Vision RT with extensive executive experience in global customer support, operations, regulatory, and R&D in the medical and life science markets. […]

by: visiort_billy

|

Categories: Press Announcements

|

0 Comments

30 January 2016. University Hospitals Seidman Cancer Center and Vision RT announce the installation of AlignRT® for Surface Guided Radiation Therapy (SGRT) in their new, state-of-the-art proton beam treatment facility. When installation is complete, the Cleveland-based proton therapy center will be the first to offer this highly specialized guidance technology for a MEVION proton machine […]

by: visiort_billy

|

Categories: Press Announcements

|

0 Comments

13 October 2015. Vision RT is pleased to announce today that a cancer clinic in Kalamazoo, Michigan, has selected AlignRT as their optical solution of choice for motion management for SRS and a range of other clinical applications, following an extensive evaluation. Recently, West Michigan Cancer Center had been searching for a replacement for the […]